在对慢阻肺病患者进行评估时，如果仅机械执行指南的要求、只判断患者症状的话，一旦发现症状加重，往往是非常严重的情况了，很不利于及早识别患者的病情恶化，那么，我们如何把功能学指标和患者的治疗选择有机结合起来？2022年的GOLD指南把「肺弥散 ...

在肺切除术术前评估领域，有一篇 1988 年发表于《The Journal of Thoracic and Cardiovascular Surgery》的文献，至今仍是指南推荐的核心依据。它首次明确了一氧化碳弥散功能（DLCO）在预测术后发病率和死亡率中的核心价值，打破了传统肺功能指标的垄断地位。今天就 ...

Monitoring blood for tiny particles released by cells lining the lungs may help clinicians diagnose emphysema in its earliest stages, according to researchers from Weill Cornell Medical College. The ...

The Social Security Administration has requested the National Academies of Sciences, Engineering, and Medicine to review the latest published research and science and produce a report addressing best ...

The diffusion capacity of the lung for carbon monoxide (DLCO) is used to measure the body's ability to transfer oxygen across the alveolar-capillary membrane. [1] Internists use this test to identify ...

ANDOVER, Mass.--(BUSINESS WIRE)--ndd Medical Technologies (ndd), a leading provider of diagnostic technology enabling healthcare professionals the early detection of COPD and other chronic lung ...

CHARLOTTESVILLE, Va., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that ...

Researchers say the test, which measures destruction of lung air sacs, could help prevent progression of the common, and fatal, lung disease emphysema. During a regular annual physical exam, blood is ...